NBY Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	9.14M
Średni wolumen	8.54M
Kapitalizacja rynkowa	5.33M
EPS	$0 ( 2024-05-28 )
Następna data zysków	( $-0.0300 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0400
ATR14	$0.00100 (0.71%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-09	Freiman Paul E.	Buy	858	Restricted Stock Units
2023-06-09	Garlikov Julie	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yenyou	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yongxiang	Buy	858	Restricted Stock Units
2023-06-09	Sit Swan	Buy	858	Restricted Stock Units

INSIDER POWER
-70.40
Last 96 transactions
Buy: 2 335 940 \| Sell: 2 184 002

Wolumen Korelacja

Długi: 0.06 (neutral)

Krótki: 0.98 (very strong)

Signal:(39.847) Expect same movement, but be aware

NovaBay Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NovaBay Pharmaceuticals Korelacja - Waluta/Towar

0.00
( neutral )

0.67
( moderate )

NovaBay Pharmaceuticals Finanse

Annual	2023
Przychody:	$14.73M
Zysk brutto:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2023
Przychody:	$14.73M
Zysk brutto:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2022
Przychody:	$14.40M
Zysk brutto:	$7.78M (54.02 %)
EPS:	$-10.10

FY	2021
Przychody:	$8.42M
Zysk brutto:	$5.65M (67.03 %)
EPS:	$-9.42

Financial Reports:

No articles found.

NovaBay Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.